Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis
- PMID: 15673743
- PMCID: PMC547312
- DOI: 10.1128/AAC.49.2.627-631.2005
Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis
Abstract
The bactericidal activity of gatifloxacin, alone and in combination with isoniazid and rifampin, was studied on both exponential- and stationary-phase cultures of Mycobacterium tuberculosis strain H37Rv. On log-phase cultures, the bactericidal activity of gatifloxacin at 4 microg/ml was rapid and was very similar to that of isoniazid. At concentrations of 0.25 and 4 microg/ml, gatifloxacin enhanced the activity of isoniazid. Killing of the stationary-phase culture was biphasic. During the first 2 days, gatifloxacin at 4 microg/ml slightly increased the limited bactericidal activities of isoniazid and rifampin. However, no further additional bactericidal activity was found during further incubation with isoniazid alone or when gatifloxacin was added to either isoniazid or rifampin. This suggested that the stationary-phase culture contained a mixture of occasionally dividing bacilli that were killed during the first 2 days and true static persisters in the residual population that mimicked those in human lesions. In view of the failure of gatifloxacin to add to the sterilizing activity of isoniazid or rifampin during days 2 to 6 of exposure in the stationary-phase culture, it is unlikely to be a sterilizing drug that can be used to shorten the duration of treatment appreciably when it is added to present treatment regimens.
Figures




Similar articles
-
Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis.J Chemother. 2006 Dec;18(6):617-23. doi: 10.1179/joc.2006.18.6.617. J Chemother. 2006. PMID: 17267339
-
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.Antimicrob Agents Chemother. 1996 Oct;40(10):2296-9. doi: 10.1128/AAC.40.10.2296. Antimicrob Agents Chemother. 1996. PMID: 8891133 Free PMC article.
-
Bactericidal activity of moxifloxacin on exponential and stationary phase cultures of Mycobacterium tuberculosis.J Chemother. 2009 Apr;21(2):127-34. doi: 10.1179/joc.2009.21.2.127. J Chemother. 2009. PMID: 19423464
-
Role of individual drugs in the chemotherapy of tuberculosis.Int J Tuberc Lung Dis. 2000 Sep;4(9):796-806. Int J Tuberc Lung Dis. 2000. PMID: 10985648 Review.
-
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.Respir Res. 2001;2(3):164-8. doi: 10.1186/rr54. Epub 2001 Apr 5. Respir Res. 2001. PMID: 11686881 Free PMC article. Review.
Cited by
-
Nitrogen deprivation induces triacylglycerol accumulation, drug tolerance and hypervirulence in mycobacteria.Sci Rep. 2019 Jun 17;9(1):8667. doi: 10.1038/s41598-019-45164-5. Sci Rep. 2019. PMID: 31209261 Free PMC article.
-
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.Antimicrob Agents Chemother. 2009 Mar;53(3):849-62. doi: 10.1128/AAC.00749-08. Epub 2008 Dec 15. Antimicrob Agents Chemother. 2009. PMID: 19075046 Free PMC article. Review. No abstract available.
-
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.Nat Rev Microbiol. 2009 Dec;7(12):845-55. doi: 10.1038/nrmicro2236. Epub 2009 Oct 26. Nat Rev Microbiol. 2009. PMID: 19855401 Free PMC article. Review.
-
Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters.mBio. 2011 Jun 14;2(3):e00100-11. doi: 10.1128/mBio.00100-11. Print 2011. mBio. 2011. PMID: 21673191 Free PMC article.
-
Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.Cell. 2011 Apr 1;145(1):39-53. doi: 10.1016/j.cell.2011.02.022. Epub 2011 Mar 3. Cell. 2011. PMID: 21376383 Free PMC article.
References
-
- Dickinson, J. M., and D. A. Mitchison. 1981. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am. Rev. Respir. Dis. 123:367-371. - PubMed
-
- Grasela, D. M. 2000. Clinical pharmacology of gatifloxacin, a new fluoroquinolone. Clin. Infect. Dis. 31:S51-S58. - PubMed
-
- Herbert, D., C. N. Paramasivan, P. Venkatesan, G. Kubendiran, R. Prabhakar, and D. A. Mitchison. 1996. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 40:2296-2299. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical